DUBLIN, June 23, 2021--(BUSINESS WIRE)--The "Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global pain management drugs market reached a value of US$ 74 Billion in 2020. Looking forward, the publisher expects the global pain management drugs market to exhibit moderate growth during the forecast period (2021-2026).
Pain management drugs perform pharmacological actions on pain receptors and work against discomfort-causing symptoms. These medications provide relief from the distressing feeling caused due to various health issues, such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer, by acting through different physiological functions. In recent years, medical advancements have led to the introduction of novel combinations and newer drug delivery techniques that provide improved pain management.
One of the key factors driving the global market is the rising geriatric population across the globe. In 2018, the population of people aged 60 years and above was around 991 million. This population is projected to reach 1.18 billion by 2024. With the prevalence of chronic pain being significantly higher in older adults, the demand for pain management drugs is escalating across the globe. Furthermore, a rise in the number of hospitalization cases and a huge demand-supply gap for effective neuropathic pain management drugs have led to the emergence of innovative and advanced therapies and medicines.
Moreover, the leading pharmaceutical companies are investing heavily in research and development (R&D) activities to develop analgesics or painkillers that are safer, more effective, economically viable and easier to administer. Other factors, including rising healthcare expenditure, improving R&D, increasing consumer awareness, and significant government support for improving healthcare services, are driving the growth of the market.
Abbott Laboratories Inc
Eli Lilly & Company
Endo International plc
F. Hoffmann-La Roche AG
Bausch Health Companies Inc
Merck & Co. Inc.
Novartis International AG
Johnson & Johnson Private Limited
Purdue Pharma L.P
Key Questions Answered in This Report:
1. What was the global pain management drugs market size in 2020?
2. What are the key global pain management drugs market drivers?
3. Who are the leading pain management drug manufacturers?
4. What is the pain management drugs market breakup by distribution channel?
5. How will the global pain management drugs market perform over the next five years (2021-2026)?
6. What is the leading drug class in the global pain management drugs market?
7. What is the major indication in the global pain management drugs market?
8. What are the major trends in the global pain management drugs market?
9. What is the impact of COVID-19 on the global pain management drugs market?
10. What are the major regions in the global pain management drugs market?
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
5 Global Pain Management Drugs Market
6 Market Breakup by Drug Class
7 Market Breakup by Indication
8 Market Breakup by Distribution Channel
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/7273k9
View source version on businesswire.com: https://www.businesswire.com/news/home/20210623005437/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900